Back to Journals » Lung Cancer: Targets and Therapy » Volume 7

Spotlight on crizotinib in the first-line treatment of ALK-positive advanced non-small-cell lung cancer: patients selection and perspectives

Total article views   HTML views PDF downloads Totals
9,291 Dovepress* 8,140+ 1,576 9,716
PubMed Central* 1,151 316 1,467
Totals 9,291 1,892 11,183
*Since 17 June 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 3 3

View citations on PubMed Central and Google Scholar